MD Pharma Consulting Group supports the preclinical phase of drug development pipeline

MD Pharma Consulting Group

Devoted to drug development

Research and Development

1- Pharmacokinetics (PK), Pharmacodynamics (PD), and PK/PD Modelling

MD Pharma Consulting Group provides Pharmacokinetic and Pharmacodynamic services that include:

  • Pharmacokinetic/Pharmacodynamic (PK/PD) Analysis.

  • Pharmacokinetic/Pharmacodynamic (PK/PD) Modelling.

  • Non-Clinical Absorption, Distribution, Metabolism, and Excretion (ADME) Studies.

 

2- Bioinformatics

MD Pharma Consulting Group Bioinformatics experts support sponsors and industry partners on various Bioinformatics applications that include:

  • Sequence Analysis.

  • Genome Assembly.

  • Gene Prediction and Genome Annotation.

  • Comparative Genomics.

  • Computer-Aided Drug Design.

 

3- Toxicology

MD Pharma Consulting Group evaluates Toxicology studies as the Single Dose Acute Toxicity studies, Repeated Dose Chronic Toxicity studies, and the Developmental and Reproductive Toxicology (DART) Studies and determines the Maximum Tolerated Dose (MTD) in accordance with ICH M3(R2), Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals.